Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study.

Dang-Tan, Tam; Kamble, Pravin S; Meah, Yunus; Gamble, Cory; Ganguly, Rahul; Horter, Libby

Dang-Tan, Tam; Kamble, Pravin S; Meah, Yunus; Gamble, Cory; Ganguly, Rahul; Horter, Libby.

Afiliación

Dang-Tan T; Novo Nordisk Inc., Plainsboro, NJ, USA. tadt@novonordisk.com.
Kamble PS; Humana Healthcare Research, Inc., Louisville, KY, USA.
Meah Y; Humana Inc., Louisville, KY, USA.
Gamble C; Novo Nordisk Inc., Plainsboro, NJ, USA.
Ganguly R; Novo Nordisk Inc., Plainsboro, NJ, USA.
Horter L; Humana Healthcare Research, Inc., Louisville, KY, USA.

Diabetes Ther ; 11(1): 213-228, 2020 Jan.

Article en En | MEDLINE | ID: mdl-31820328

Palabras clave

Clinical outcomes; Liraglutide; Older adults; Sitagliptin; Type 2 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetes Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google